Sort
30,917 grants matching “tumor microenvironment”
Vaccine and radiation for the therapy of human cancers
$573,692James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Intratumor co-delivery of DNA and RNA to relieve cancer pain
$573,679Brian L Schmidt · New York University · R01 · FY2022 · DE
Elucidating genetics of response to immune checkpoint blockade in lung cancer
$573,644Naiyer A Rizvi · Columbia University Health Sciences · R01 · FY2017 · CA
Activating Native Tumor Immunity with IL-33 Armored CARs
$573,520Yina Hsing Huang · Dartmouth College · R01 · FY2023 · CA
The role of inflammation in the regulation of immune response in acute myeloid leukemia
$573,470Iannis Aifantis · New York University School Of Medicine · R01 · FY2025 · CA
Modulation of Tumor Microenvironment for Improved Therapy of Pancreatic Cancer
$573,438Maneesh Jain · University Of Nebraska Medical Center · R01 · FY2024 · CA
Penn Quantitative MRI Resource for Pancreatic Cancer
$573,399Rong Zhou · University Of Pennsylvania · U24 · FY2018 · CA
Dissect governing factors for tumor stem cell dormancy in biomimetic vascular/GBM model
$573,350Hongyan Jenny Zou · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · NS
PHOTOACOUSTIC MICROSCOPY OF NEOVASCULARIZATION IN RENAL CANCER GROWTH AND THERAPY
$573,291Jeffrey Michael Arbeit · Washington University · R01 · FY2014 · CA
Neutrophil derived proteinases abolish the IFNG signature in NSCLC
$573,105A. McGarry Houghton · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
Center for Environment-Mediated Drug Resistance in Pediatric Cancer
$573,087Yves A Declerck · Children'S Hospital Of Los Angeles · U54 · FY2012 · CA
Combine mitochondrial gene therapy and synthetic lethal chemotherapy to treat triple-negative breast cancer
$573,078Xiaoguang Margaret Liu · Ohio State University · R01 · FY2025 · CA
Leveraging Vulnerabilities Induced by STING Activation in Pancreatic Cancer
$572,887Timothy R Donahue · University Of California Los Angeles · R01 · FY2025 · CA
Interleaved 1H/23Na imaging for invasive and proliferative phenotypes of brain tumors
$572,851Dewan Syed Fahmeed Hyder · Yale University · R01 · FY2023 · CA
Develop Conditionally Armored CAR Macrophage Therapy for Pancreatic Cancer
$572,707Pingping Hou · Rutgers Biomedical And Health Sciences · R01 · FY2024 · CA
A biophysical stromal basis for radiation sensitivity in ductal carcinoma in situ
$572,699Catherine C Park · University Of California, San Francisco · R01 · FY2017 · CA
The Role of HIF2 in Pancreatic Ductal Adenocarcinoma
$572,667Cullen Mitsuo Taniguchi · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
The Role of HIF2 in Pancreatic Ductal Adenocarcinoma
$572,667Albert Koong · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Research Test-Bed Unit
$572,616Daniela E Matei · Northwestern University · U54 · FY2025 · CA
Developmental Funds
$572,612Eric R. Fearon · University Of Michigan At Ann Arbor · P30 · FY2023 · CA
Mouse Models of Metastatic Triple-Negative Breast Cancer for Therapeutic Testing
$572,521Charles M Perou · Univ Of North Carolina Chapel Hill · R01 · FY2016 · CA
Kinetic Assembly of Polymer-mRNA Nanoparticles Targets Circulating Monocytes to Enhance Cancer Immunotherapy
$572,485Hai-Quan Mao · Johns Hopkins University · R01 · FY2025 · CA
Harnessing TNFa Signaling To Improve Therapeutic Response In Pancreatic Cancer
$572,447Kian H Lim · Washington University · R01 · FY2024 · CA
Immunotherapy Strategies for Uveal Melanoma
$572,312Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Impact of malaria on shaping immunity to EBV in the etiology of Burkitt lymphoma
$572,221Ann M Moormann · Univ Of Massachusetts Med Sch Worcester · R01 · FY2015 · CA